CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) Financings
Financings
| Raise | Date |
|---|---|
| Private placement of common stock and pre-funded warrants Announced: about US$22.5M · US$2.3 a share · A.G.P./Alliance Global Partners Dealers: A.G.P./Alliance Global Partners (lead) Buyers: ADAR1 Capital; Ikarian Capital; Stonepine Capital Management; Nazare Partners Use of proceeds: To identify, acquire and advance differentiated clinical assets, plus working capital and general corporate purposes | May 4, 2026 |
| Public offering of shares of common stock and Series F common stock purchase warrants Closed: US$5M raised · US$1.265 a share · Warrants at US$1.14 for 60 months · A.G.P./Alliance Global Partners Dealers: A.G.P./Alliance Global Partners (lead) Use of proceeds: Together with cash on hand, to fund planned operations into the second half of 2026 | May 16, 2025 |